MARKetTIME NEWS

[MARKetTIME]

ChromaDex, Corp. Issued a $2.20 Price Target and 'STRONG BUY' Rating
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=808882&ProfileId=051205&sourceType=1
NEW YORK, NY -- (Marketwire) -- 10/13/11 -- ChromaDex Corp., (OTCBB: CDXC) has recently been issued a $2.20 price target and rated a 'STRONG BUY' by RedChip Research, the full report is available here; http://redchip.com/visibility/investor.asp?symbol=CDXC&from=scnr

ChromaDex has positioned itself in the $151 billion natural products industry alongside so very big players in the industry like Pfizer (NYSE: PFE), Kraft Foods (NYSE: KFT) and Nutraceutical Int'l Corp (NASDAQ: NUTR). Nutraceuticals and natural products are two of the fastest growing industries with a value of nearly $86 billion for the US alone. As the "baby boomer" generation ages, nutraceuticals and natural products will continue to flourish.

Chromadex's first proprietary product is pTeroPure® which is based on an antioxidant found in blueberries. It has been shown to promote a healthy heart, healthy aging and improve cognitive functions. pTeroPure was given "Most Promising Ingredient of the Year" by Frost and Sullivan and is projected to have a market value of $465+ in the next 5 years.

To read more on ChromaDex, Corp. please visit http://redchip.com/visibility/investor.asp?symbol=CDXC&from=scnr

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid Equity News Alert twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact:
Equity News Alert
Email Contact